Order Article Reprints

Liu X, Chang X, Rothen D, Derveni M, Krenger P, Roongta S, Wright E, Vogel M, Tars K, Mohsen MO, et al. AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate. Vaccines. 2021; 9(4):403. https://doi.org/10.3390/vaccines9040403

Liu, Xuelan, Xinyue Chang, Dominik Rothen, Mariliza Derveni, Pascal Krenger, Salony Roongta, Edward Wright, Monique Vogel, Kaspars Tars, Mona O. Mohsen, and et al. 2021. "AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate" Vaccines 9, no. 4: 403. https://doi.org/10.3390/vaccines9040403

Liu, X., Chang, X., Rothen, D., Derveni, M., Krenger, P., Roongta, S., Wright, E., Vogel, M., Tars, K., Mohsen, M. O., & Bachmann, M. F. (2021). AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate. Vaccines, 9(4), 403. https://doi.org/10.3390/vaccines9040403